PeptidPRO® is an innovative Russian pharmaceutical company focused on the development and clinical application of regulatory peptides. The company aims to transform medical treatments by creating effective and safe medications for various socially significant health issues, including male infertility, overactive bladder syndrome, and peripheral atherosclerosis.

Founded in 2016, PeptidPRO® has achieved significant milestones, including the completion of clinical studies for three original injectable drugs designed to improve patients' quality of life. Their mission is to change the perceptions of doctors and patients about disease prevention and treatment, emphasizing a therapeutic approach that goes beyond merely alleviating symptoms.

PeptidPRO® collaborates with leading scientific laboratories and adopts modern production technologies, ensuring high-quality standards in their products. By constantly exploring the therapeutic potential of peptides, PeptidPRO® is committed to revolutionizing clinical practices and offering promising treatment solutions that encourage healthier living. Their dedication to innovative drug development makes them a leader in the field of peptide pharmacotherapy.